2m 2m 2m 2m 2m 2m 2m
NUTRIBAND (NTRB)
NASDAQ
$3.09+$0.04 (+1.15%)
Price as of Jun 23, 2026 4:10 PM EDT- $37.8MMarket Cap
- -59.72%1-Year Change
- BiotechnologyIndustry
NUTRIBAND (NTRB)
$3.09+$0.04 (+1.15%)
Annual
Quarterly
01/31/2026 | 01/31/2025 | 01/31/2024 | 01/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | 2.1M +2.60% | 2.1M +0.27% | 2.1M +46.23% | |
Cost of Revenue | 1.5M +5.31% | 1.4M +14.14% | 1.2M -7.97% | 1.3M +44.82% | |
Gross Profit | -1.5M -297.81% | 743,317 -13.78% | 862,105 +14.89% | 750,404 +35.38% | |
Sales and Marketing Expense | 7.0M +62.11% | 4.3M +14.32% | 3.8M -3.64% | 3.9M -2.65% | |
Research and Development Expense | -1.9M -39.37% | -3.1M +59.10% | -2.0M +99.59% | -982,227 +138.76% | |
Depreciation and Amortization Expense | 60,665 -78.72% | 285,054 -0.93% | 287,722 -12.85% | 330,143 +6.93% | |
Total Operating Expenses | 10.4M -16.66% | 12.4M +78.58% | 7.0M +6.14% | 6.6M -12.98% | |
Operating Profit | -8.3M -19.12% | -10.3M +111.10% | -4.9M +8.87% | -4.5M -26.77% | |
Interest Income | 110,864 -42.16% | 191,669 +1,037.50% | 16,850 N/A | N/A N/A | |
Interest Expense | 0 +100.00% | -60,453 -20.26% | -75,815 +814.65% | -8,289 -93.00% | |
Interest Income and Expense and Net | 110,864 -15.51% | 131,216 +322.53% | -58,965 +611.36% | -8,289 -93.00% | |
Total Nonoperating Income and Expense | 88,329 +144.66% | -197,774 -67.76% | -613,388 +7,300.02% | -8,289 -87.32% | |
Income before Taxes | -8.2M -21.49% | -10.5M +91.10% | -5.5M +22.35% | -4.5M -27.41% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | 3.3M +414.01% | -1.1M 0.00% | -1.1M -148.23% | |
Net Income | -30.0M +186.61% | -10.5M +91.10% | -5.5M +22.35% | -4.5M -27.41% | |
Net Income from Continuing Operations Applicable to Common | -30.0M +186.61% | -10.5M +91.10% | -5.5M +22.35% | -4.5M -29.65% | |
Basic EPS and Net Income | -2.58 +160.61% | -0.99 +43.48% | -0.69 +30.19% | -0.53 -43.62% | |
Diluted EPS and Net Income | -2.58 +160.61% | -0.99 +43.48% | -0.69 +30.19% | -0.53 -43.62% | |
Basic Weighted Average Shares | 11.6M +9.74% | 10.6M +33.36% | 8.0M -5.97% | 8.5M +24.41% | |
Diluted Weighted Average Shares | 11.6M +9.74% | 10.6M +33.36% | 8.0M -5.97% | 8.5M +24.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.6M +6.10% | 4.3M +774.69% | 492,942 -75.17% | 2.0M -59.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.6M +6.10% | 4.3M +774.69% | 492,942 -75.17% | 2.0M -59.41% | |
Total Current Assets | 5.0M +4.06% | 4.8M +369.17% | 1.0M -62.07% | 2.7M -50.71% | |
Accumulated Depreciation | 986,729 +15.60% | 853,597 +25.22% | 681,693 +34.42% | 507,121 +56.78% | |
Property and Plant and Equipment and Net | N/A N/A | 695,063 -10.31% | 774,924 -13.68% | 897,735 -8.33% | |
Total Long-Term Assets | N/A N/A | 695,063 -10.31% | 774,924 -13.68% | 897,735 -8.33% | |
Total Assets | 7.5M +1.04% | 7.5M -0.63% | 7.5M -20.51% | 9.5M -25.77% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 128,871 +0.57% | 128,144 +0.76% | 127,183 +544.29% | 19,740 +39.81% | |
Total Current Liabilities | 784,281 -20.20% | 982,845 -1.63% | 999,093 +33.46% | 748,613 -3.93% | |
Total Long-Term Debt | 35,861 -38.39% | 58,205 -27.09% | 79,826 -20.57% | 100,497 -0.62% | |
Total Long-Term Liabilities | 84,166 +44.60% | 58,205 -27.09% | 79,826 -20.57% | 100,497 -0.62% | |
Total Liabilities | 868,447 -16.58% | 1.0M -3.51% | 1.1M +22.13% | 883,387 +0.34% | |
Retained Earnings | -46.7M +21.40% | -38.5M +37.46% | -28.0M +24.38% | -22.5M +24.89% | |
Total Stockholders Equity | 6.7M +3.90% | 6.4M -0.14% | 6.4M -24.90% | 8.6M -27.71% | |
Total Shares Outstanding | 12.2M +9.76% | 11.1M +25.00% | 8.9M +13.11% | 7.8M -0.13% | |
Cash Flow | |||||
Cash from Operating Activities | -5.1M +10.98% | -4.6M +31.16% | -3.5M +18.09% | -3.0M +6.34% | |
Capital Expenditures | 5,324 -94.22% | 92,043 +77.82% | 51,761 -34.73% | 79,304 -2.81% | |
Cash from Investing Activities | -5,324 -94.22% | -92,043 +77.82% | -51,761 -34.73% | -79,304 -2.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.4M -36.71% | 8.5M +309.12% | 2.1M +1,203.63% | 160,074 -97.90% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 34.74% -15.96% | 41.34% +14.57% | 36.08% +1.76% | |
Operating Margin | N/A N/A | -480.70% +105.75% | -233.63% +8.57% | -215.19% -49.92% | |
Return on Assets | -400.11% +186.02% | -139.89% +116.43% | -64.63% +59.99% | -40.40% -25.87% | |
Return on Equity | -458.39% +181.33% | -162.94% +122.95% | -73.08% +66.53% | -43.89% -32.60% | |
Revenue Growth | N/A N/A | 2.60% +847.94% | 0.27% -99.41% | 46.23% -8.82% | |
Current Ratio | 6.36 +30.40% | 4.88 +376.92% | 1.02 -71.58% | 3.60 -48.70% | |
Cash Ratio | 5.83 +32.97% | 4.39 +789.14% | 0.49 -81.40% | 2.65 -57.75% | |
Debt-to-Equity Ratio | 0.02 -14.83% | 0.03 -9.94% | 0.03 +130.00% | 0.01 +44.33% | |
Debt-to-Assets Ratio | 0.02 -12.45% | 0.02 -9.45% | 0.03 +116.54% | 0.01 +41.11% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow